Definitive Healthcare Q3 revenue falls 9% to $54.7 million; no guidance amid Advent bid
Definitive Healthcare reported third-quarter 2026 revenue of $54.7 million, down 9% from $60.0 million a year earlier, and Adjusted EBITDA of $15.7 million, down from $18.9 million. Its GAAP net loss narrowed to $5.4 million from $17.8 million, but the company will not give financial guidance or hold a call because its special committee received a non-binding acquisition proposal from Advent International.
Key points
- Q3 2026 revenue was $54.7 million, down 9% from $60.0 million in Q3 2025.
- Net loss was $5.4 million, compared with $17.8 million in Q3 2025; Adjusted Net Income was $8.8 million, compared with $9.7 million.
- Adjusted EBITDA was $15.7 million, or 29% of revenue, compared with $18.9 million, or 32%, a year earlier.
- The company will provide no financial guidance and no conference call, citing a non-binding Advent International indication of interest to acquire shares not already owned by Advent or founder Jason Krantz.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.